Atlas Trials

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Clinical trial NCT00080678 · COMPLETED

Trial details

NCT number
NCT00080678
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic CancerProstate Cancer
Start date
2003-05-01
Primary completion
2005-08-01
Enrollment
116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.